Skip to content

Recreative soccer and risk for cardiovascular and metabolic diseases in obese adolescents

Soccer as a novel therapeutic approach to pediatric obesity. A randomized controlled trial and its effects on fitness, body composition, cardiometabolic and oxidative markers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20150512001
Enrollment
Unknown
Registered
2015-05-12
Start date
2013-01-10
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome body composition cardiorespiratory fitness inflammatory markers sports exercise health

Interventions

Participants were randomly selected among adolescents attended by the Nucleus for Studies on Adolescent Health of the University of Rio de Janeiro State (NSAH)&#44
Brazil&#44
where they were provided systematically medical&#44
psychological&#44
and nutritional assistance. A sample of 32 obese adolescents qualified for the study (10 girls) (mean&#177
age=14.5&#177
1.6 yrs)&#44
being randomly assigned to experimental and non&#45
exercise control groups. The control group was instructed not to change their regular physical activity habits. The soccer intervention consisted in three sessions per week during 12 weeks at the Univ
up followed by 40 min of games performed in small pitch areas (such as 2 vs. 2&#44
3 vs. 3 and 4 vs. 4)&#44
and 10&#45
down. Training intensity was recorded by portable heart rate monitors (Polar RS800cx&#44
PolarTM&#44
Kempele&#44
Finland). Two licensed exercise instructors supervised the training sessions.
Experimental Behavioral
recreational soccer program

Sponsors

University of Porto
Lead Sponsor
University of Rio de Janeiro State
Collaborator

Eligibility

Sex/Gender
All
Age
12 Years to 17 Years

Inclusion criteria

Inclusion criteria: Healthy volunteers; both sexes; non smokers; age between 12 and 17 years; BMI above 2 standard deviations of references values established by the WHO for sex and age; Tanner maturation stages based on pubic hair between 4 and 5.

Exclusion criteria

Exclusion criteria: Medical conditions contraindicating the participation in physical activities; use of medication influencing metabolic or cardiovascular function; participation in weight management programs within 6 months prior to the experiment.

Design outcomes

Primary

MeasureTime frame
Anthropometric measurements (body mass, height, hip circumference, waist circumference) 12 weeks after the beginning of intervention Digital scale, fixed stadiometer, metal anthropometric tape.,Blood pressure at rest 12 weeks after the beginning of intervention automated Omron 705IT device,Cardiorespiratory fitness 12 weeks after the beginning of intervention incremental cardiopulmonary stress test performed on a cycle ergometer,Lipid blood profile (tryglicerides, colestherol, LDL, HDL 12 weeks after the beginning of intervention Determined fluorometrically using an automated analyzer and enzymatic kits,Insulin levels and C-reactive protein 12 weeks after the beginning of intervention enzyme immunoassay ELISA kit and highly sensitive latex with an automatic analyzer,Oral glucose tolerance and HOMA-IR 12 weeks after the beginning of intervention blood sample after 12h fasting followed by ingestion of 75g of dextrose,endothelial function 12 weeks after the beginning of intervention enous occlusion plethysmography,Adiponectin, interleukin-6 (IL-6), leptin, tumor necrosis factor-alpha (TNF-alfa) 12 weeks after the beginning of intervention ELISA (Enzyme Linked Immunosorbent Assay),non-esterified fatty acids (NEFA) 12 weeks after the beginning of intervention enzymatic colorimetric assay method

Secondary

MeasureTime frame
biological maturity stage 12 weeks after the beginning of intervention maturation of pubic hair evaluated in pediatric clinical examination,heart rate variability 12 weeks after the beginning of intervention heart rate monitor (Polar RS800CX, PolarTM, Kempele, Finland)

Countries

Portugal

Contacts

Public ContactAndré Seabra

University of Porto

aseabra@fade.up.pt+351-225500689

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026